🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

33+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 33 recruiting trials for “mild-hemophilia-a

Phase 4RecruitingNCT07406139

PCC Treatment for Hemophilia Patients With Inhibitor(2022PCC-A)

🏥 Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Mar 2026View details ↗
Phase 3RecruitingNCT04563520

SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis

👨‍⚕️ Robert Sidonio, MD, Emory University📍 2 sites📅 Started Mar 2026View details ↗
RecruitingNCT07101926

Monitoring of Anti-TFPI in Hemophilia

🏥 Hospices Civils de Lyon📍 2 sites📅 Started Oct 2025View details ↗
Phase 4RecruitingNCT06941870

Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy

🏥 Sanofi📍 13 sites📅 Started Sep 2025View details ↗
RecruitingNCT07314983

Long-term Anticoagulation in a Patient With Severe Hemophilia A

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started Sep 2025View details ↗
RecruitingNCT06550882

A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea

👨‍⚕️ Study Director, Takeda📍 1 site📅 Started Jul 2025View details ↗
Phase 4RecruitingNCT06940830

Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa

👨‍⚕️ Study Physician, Swedish Orphan Biovitrum AB (publ)📍 27 sites📅 Started May 2025View details ↗
Phase 1RecruitingNCT06703606

A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

👨‍⚕️ Pfizer CT.gov Call Center, Pfizer📍 4 sites📅 Started May 2025View details ↗
Phase 3RecruitingNCT06833983

To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A

🏥 Gritgen Therapeutics Co., Ltd.📍 13 sites📅 Started Mar 2025View details ↗
NARecruitingNCT06816056

Manual Therapy in Hemophilic Arthropathy of the Ankle

👨‍⚕️ Rubén Cuesta-Barriuso, PhD, Universidad de Oviedo📍 1 site📅 Started Feb 2025View details ↗
Phase 3RecruitingNCT06700096

An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B

👨‍⚕️ Arina Arina V Zinkina-Orikhan, Biocad📍 14 sites📅 Started Nov 2024View details ↗
NARecruitingNCT06565481

Measurement Properties in People with Hemophilia

👨‍⚕️ Ruud Knols, PhD, University of Zurich📍 1 site📅 Started Oct 2024View details ↗
Enrolling by InvitationNCT06826209

Comparison of Upper Extremity Functional Performance in Hemophilic and Healthy Children

🏥 Hacettepe University📍 1 site📅 Started Oct 2024View details ↗
Phase 1, PHASE2RecruitingNCT06379789

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 40 sites📅 Started Sep 2024View details ↗
NARecruitingNCT06580340

Effectiveness of an Adapted Physical Activity Program for Subjects Suffering From Haemophilia

🏥 Istituto Ortopedico Rizzoli📍 1 site📅 Started Sep 2024View details ↗
NAEnrolling by InvitationNCT07259356

Feasibility and Safety of Blood-Flow-Restriction Training in Patients With Hemophilia

🏥 University Hospital, Bonn📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06461533

A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A

👨‍⚕️ Study Director, Takeda📍 1 site📅 Started Jun 2024View details ↗
Phase 3RecruitingNCT07437404

Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.

🏥 Sinocelltech Ltd.📍 1 site📅 Started Apr 2024View details ↗
Phase 4RecruitingNCT06145373

A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab

👨‍⚕️ Clinical Sciences & Operations, Sanofi📍 2 sites📅 Started Mar 2024View details ↗
Phase 4RecruitingNCT05935358

Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study

👨‍⚕️ Shveta Gupta, MD, Arnold Palmer Hospital for Children📍 18 sites📅 Started Nov 2023View details ↗
Page 1 of 2Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →